삼성서울병원

Ko En
의료진 검색
찾으실 의료진명을 입력하여 검색해주세요.

비뇨의학과 서성일 교수

진료분야
신장암, 전립선암, 로봇수술, 복강경수술
진료일정 03 月
날짜
수
01
목
02
금
03
토
04
일
05
월
06
화
07
수
08
목
09
금
10
토
11
일
12
월
13
화
14
수
15
목
16
금
17
토
18
일
19
월
20
화
21
수
22
목
23
금
24
토
25
일
26
월
27
화
28
수
29
목
30
금
31
오전
오후
진료일정 04 月
날짜
토
01
일
02
월
03
화
04
수
05
목
06
금
07
토
08
일
09
월
10
화
11
수
12
목
13
금
14
토
15
일
16
월
17
화
18
수
19
목
20
금
21
토
22
일
23
월
24
화
25
수
26
목
27
금
28
토
29
일
30
오전
오후
본원외래 본원클리닉 본원육아상담 암병원외래 암병원클리닉 암병원육아상담

학력

학력
2002.08 가톨릭대학교 대학원 의학과 (박사)
1998.02 서울대학교 대학원 의학과 (석사)
1992.02 서울대학교 의과대학 졸업 (의학사)

경력

경력
2016.04 ~현재 성균관대학교 비뇨의학과 교수
2010.03 ~ 2016.03 성균관대학교 비뇨의학과 부교수
2010.03 ~ 2014.02 삼성서울병원 비뇨의학과 의국장
2007.09 ~ 2010.02 삼성서울병원 비뇨의학과 임상부교수
2004.04 ~ 2007.08 가톨릭대학교 강남성모병원 조교수
2005.09 ~ 2006.10 미국 Emory대학 Winship Cancer Institute 연수
2002.04 ~ 2004.03 가톨릭대학교 강남성모병원 전임강사
1998.03 ~ 2002.03 가톨릭대학교 강남성모병원 임상강사
1998.03 비뇨의학과 전문의 자격취득
1994.03 ~ 1998.02 서울대학교병원 비뇨의학과 레지던트과정 수료
1993.03 ~ 1994.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2023.01 ~ 현재 대한비뇨의학재단 감사
2018.08 ~ 현재 대한비뇨기종양학회 이사
2011.03 ~ 현재 아시아태평양전립선학회 이사
2021.03 ~ 2023.02 대한전립선학회 회장
2019.01 ~ 2022.12 대한비뇨의학회 학술이사
2019.03 ~ 2021.02 대한전립선학회 부회장
2018.08 ~ 2020.12 대한비뇨기종양학회 신암연구회 위원장
2017.03 ~ 2019.02 대한전립선학회 학술이사
2013.03 ~ 2017.02 대한전립선학회 총무이사
논문
  • CURR ISSUES MOL BIOL 2021 10.3390/cimb43010019 Renal Cell Carcinoma-Infiltrating CD3(low) V gamma 9V delta 1 T Cells Represent Potentially Novel Anti-Tumor Immune Players Lee1, HW; Park, C; Joung, JG; Kang, MY; Chung, YS; Oh, WJ; Yeom, SY; Park, WY; Kim, TJ; Seo, SI
    View PubMed
  • PLOS ONE 2021 10.1371/journal.pone.0249709 Biochemical recurrence after radical prostatectomy according to nadir prostate specific antigen value Chung1, JH; Jeong, JY; Lee, JY; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • CELLS 2021 10.3390/cells10040917 Pattern of Tumor-Infiltrating Lymphocytes in Mixed Epithelial and Stromal Tumor of the Kidney: A Review of Five Cases Lee1, HW; Lee, H; Park, C; Oh, WJ; Kim, TJ; Kwon, GY; Seo, SI
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-87573-5 Comparison of oncologic and functional outcomes between radical nephroureterectomy and segmental ureterectomy for upper urinary tract urothelial carcinoma Kim1, TH; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • BIOLOGY-BASEL 2021 10.3390/biology10040297 Assessment of Agreement between Two Difference Prostate-Specific Antigen Assay Modalities Chung1, JH; Park, M; Cho, H; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • INVESTIG CLIN UROL 2021 10.4111/icu.20200406 Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance Yu1, J; Cho, E; Choi, J; Lim, JE; Lee, J; Kang, M; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-85099-4 Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma Kim1, YJ; Kang, Y; Kim, JS; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Park, D; Park, WY; Kang, M
    View PubMed
  • INT J UROL 2021 10.1111/iju.14485 Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database Lee1, CH; Chung, J; Kwak, C; Jeong, CW; Seo, SI; Kang, M; Hong, SH; Song, C; Park, JY; Hwang, EC; Lee, H; Ku, JY; Seo, WI; Choi, SH; Ha, HK
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200084 Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL Choi1, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • J KOREAN MED SCI 2020 10.3346/jkms.2020.35.e342 Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL) Chung1, JH; Yu, J; Song, W; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • J SURG ONCOL 2020 10.1002/jso.26251 Metastatic renal cell carcinoma to the pancreas Clinical features and treatment outcome Shin1, TJ; Song, C; Jeong, CW; Kwak, C; Seo, S; Kang, M; Chung, J; Hong, SH; Hwang, EC; Park, JY; Lee, H
    View PubMed
  • J CANCER 2020 10.7150/jca.48062 Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors A Propensity-Score Matching Analysis Kang1, M; Choi, J; Kim, J; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Park, SH; Song, C; Seo, SI
    View PubMed
  • INT J SURG 2020 10.1016/j.ijsu.2020.07.006 Relationship between robotic-assisted radical prostatectomy and retropubic radical prostatectomy in the learning curve of a single surgeon as a novice in radical prostatectomy A retrospective cohort study Song1, W; Lee, SW; Chung, JH; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Jeon, SS
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.20200002 The platelet-to-lymphocyte ratio as a significant prognostic factor to predict survival outcomes in patients with synchronous metastatic renal cell carcinoma Yuk1, HD; Kang, M; Hwang, EC; Park, JY; Jeong, CW; Song, C; Seo, SI; Byun, SS; Kwak, C; Hong, SH; Chung, J; Lee, H
    View PubMed
  • PROSTATE INT 2020 10.1016/j.prnil.2020.03.003 Detection of prostate cancer using prostate imaging reporting and data system score and prostate-specific antigen density in biopsy-naive and prior biopsy-negative patients Ryoo1, H; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • DIS MARKERS 2020 10.1155/2020/8887605 Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment Kang1, M; Shin, SJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • J HEPATOL 2020 10.1016/j.jhep.2020.01.010 Functions of human liver CD69(+)CD103(-)CD8(+) T cells depend on HIF-2 alpha activity in healthy and pathologic livers Kim1, JH; Han, JW; Choi, YJ; Rha, MS; Koh, JY; Kim, KH; Kim, CG; Lee, YJ; Kim, AR; Park, J; Kim, HK; Min, BS; Il Seo, S; Kang, M; Park, HJ; Han, DH; Il Kim, S; Kim, MS; Lee, JG; Lee, DH; Kim, W; Park, JY; Park, SH; Joo, DJ; Shin, EC
    View PubMed
  • INVESTIG CLIN UROL 2020 10.4111/icu.2020.61.3.260 Development of the clinical calculator for mortality of patients with metastatic clear cell type renal cell carcinoma: An analysis of patients from Korean Renal Cancer Study Group database Park1, JY; Tae, BS; Jeong, CW; Song, C; Seo, SI; Hong, SK; Chung, J; Hong, SH; Hwang, EC; Kwak, C; Seo, IY; Park, S; Park, C
    View PubMed
  • CANCERS 2020 10.3390/cancers12040866 Integrative Radiogenomics Approach for Risk Assessment of Post-Operative Metastasis in Pathological T1 Renal Cell Carcinoma: A Pilot Retrospective Cohort Study Lee1, HW; Cho, HH; Joung, JG; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Nam, DH; Park, WY; Kim, CK; Seo, SI; Park, H
    View PubMed
  • APPL SCI-BASEL 2020 10.3390/app10041333 Prediction System for Prostate Cancer Recurrence Using Machine Learning Lee1, SJ; Yu, SH; Kim, Y; Kim, JK; Hong, JH; Kim, CS; Il Seo, S; Byun, SS; Jeong, CW; Lee, JY; Choi, IY
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2019.07.014 Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors Shin1, SJ; Kim, T; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI; Kang, M
    View PubMed
  • J ENDOUROL 2019 10.1089/end.2019.0410 Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.6.454 The clinical utility of transperineal template-guided saturation prostate biopsy for risk stratification after transrectal ultrasound-guided biopsy Song1, W; Kang, M; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.604 Atezolizumab in Patients with Pretreated Urothelial Cancer: A Korean Single-Center, Retrospective Study Hur1, JY; Kim, Y; Kwon, GY; Kang, M; Sung, HH; Jean, HG; Jeong, BC; Seo, SI; Jean, SS; Lee, HM; Lee, SJ; Park, SH
    View PubMed
  • UROL INT 2019 10.1159/000501527 Cancer Location in Upgrading and Detection after Transperineal Template-Guided Mapping Biopsy for Patients in Active Surveillance and Negative Transrectal Ultrasonography-Guided Prostate Biopsy Lee1, CU; Sung, SH; Jang, CT; Kang, M; Sung, HH; Jeong, BC; Il Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • WORLD J UROL 2019 10.1007/s00345-018-02617-2 Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer Choi1, YH; Yu, JW; Kang, MY; Sung, HH; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CUAJ-CAN UROL ASSOC 2019 10.5489/cuaj.5605 Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma Kim1, TH; Kang, YT; Cho, YH; Kim, JH; Jeong, BC; Seo, SL; Jeon, SS; Lee, HM
    View PubMed
  • Cancer Med 2019 10.1002/cam4.2222 Survival and clinical prognostic factors in metastatic non-clear cell renal cell carcinoma treated with targeted therapy: A multi-institutional, retrospective study using the Korean metastatic renal cell carcinoma registry Kim1, JK; Kim, SH; Song, MK; Joo, J; Seo, SI; Kwak, C; Jeong, CW; Song, C; Hwang, EC; Seo, IY; Lee, H; Hong, SH; Park, JY; Chung, J
    View PubMed
  • INVESTIG CLIN UROL 2019 10.4111/icu.2019.60.4.227 Genomic analysis of Korean patients with advanced prostate cancer by use of a comprehensive next-generation sequencing panel and low-coverage, whole-genome sequencing Kang1, M; Cho, E; Jang, J; Lee, J; Jeon, Y; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Jeon, HG
    View PubMed
  • INT J SURG 2019 10.1016/j.ijsu.2019.04.013 Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study Song1, W; Jeong, JY; Jeon, HG; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Sung, HH
    View PubMed
  • J NATL COMPR CANC NE 2019 10.6004/jnccn.2018.7265 Is Primary Androgen Deprivation Therapy a Suitable Option for Asian Patients With Prostate Cancer Corn red With Radical Prostatectomy? Ha1, US; Choi, JB; Shim, JI; Kang, M; Park, E; Kang, S; Park, J; Yang, J; Choi, I; Ahn, J; Kwak, C; Jeong, CW; Kim, CS; Byun, SS; Seo, SI; Lee, HM; Lee, SJ; Lee, SH; Chung, BH; Lee, JY
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S199432 Predictors of postoperative complications after robot-assisted radical cystectomy with extracorporeal urinary diversion Lee1, CU; Kang, M; Kim, TJ; Na, JP; Sung, HH; Jeon, HG; Seo, S; Jeon, SS; Lee, HM; Jeong, BC
    View PubMed
  • PROSTATE 2019 10.1002/pros.23766 A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation Choi1, YH; Han, DH; Kim, SW; Kim, MJ; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2019 10.1186/s12894-019-0463-7 A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer Yoon1, SE; Kim, Y; Cho, J; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Lee, SJ; Park, SH
    View PubMed
  • JSLS-J SOC LAPAROENDOSC SURG 2019 10.4293/JSLS.2019.00008 Laparoscopic Ureterolithotomy vs Ureteroscopic Lithotripsy for Large Ureteral Stones Choi1, AD; Seo, SI; Kwon, J; Kim, BS
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.421 Application of the International Metastatic Renal Cell Carcinoma Database Consortium and Memorial Sloan Kettering Cancer Center Risk Models in Patients with Metastatic Non-clear Cell Renal Cell Carcinoma: A Multi-institutional Retrospective Study Using the Korean Metastatic Renal Cell Carcinoma Registry Kim1, JK; Kim, SH; Song, MK; Joo, J; Seo, SI; Kwak, C; Jeong, CW; Song, C; Hwang, EC; Seo, IY; Lee, H; Hong, SH; Park, JY; Chung, J
    View PubMed
  • SCI REP-UK 2019 10.1038/s41598-019-42739-0 Transperitoneal radical nephroureterectomy is associated with worse disease progression than retroperitoneal radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma Kim1, TH; Suh, YS; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Sung, HH
    View PubMed
  • CLIN GENITOURIN CANC 2019 10.1016/j.clgc.2018.09.007 Comparison of Cancer Detection Rates Between TRUS-Guided Biopsy and MRI-Targeted Biopsy According to PSA Level in Biopsy-Naive Patients: A Propensity Score Matching Analysis Choi1, YH; Kang, MY; Sung, HH; Eon, HG; Jeong, BC; Seo, SI; Jeon, SS; Kim, CK; Park, BK; Lee, HM
    View PubMed
  • KOREAN J RADIOL 2019 10.3348/kjr.2018.0613 Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2 Kim1, R; Kim, CK; Park, JJ; Kim, JH; Seo, SI; Jeon, SS; Lee, HM
    View PubMed
  • Cancer Manag Res 2019 10.2147/CMAR.S185796 Incidences and oncological outcomes of urothelial carcinoma in kidney transplant recipients Yu1, J; Lee, CU; Kang, M; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Sung, HH
    View PubMed
  • DIAGN PATHOL 2019 10.1186/s13000-019-0782-8 Histological characteristics of the largest and secondary tumors in radical prostatectomy specimens and implications for focal therapy Choi1, YH; Yu, JW; Jeong, BC; Seo, S; Jeon, SS; Lee, HM; Jeon, HG
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.07.030 Oncologic Outcomes of Cytoreductive Nephrectomy in Synchronous Metastatic Renal-Cell Carcinoma: A Single-Center Experience Choi1, CI; Kang, M; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SIL
    View PubMed
  • ANN ONCOL 2018 10.1093/annonc/mdy454 Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial Gross-Goupil1, M; Kwon, TG; Eto, M; Ye, D; Miyake, H; Seo, SI; Byun, SS; Lee, JL; Master, V; Jin, J; DeBenedetto, R; Linke, R; Casey, M; Rosbrook, B; Lechuga, M; Valota, O; Grande, E; Quinn, DI
    View PubMed
  • J KOREAN MED SCI 2018 10.3346/jkms.2018.33.e325 Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib Kim1, MS; Chung, HS; Hwang, EC; Jung, SI; Kwon, DD; Hwang, JE; Bae, WK; Park, JY; Jeong, CW; Kwak, C; Song, C; Seo, SI; Byun, SS; Hong, SH; Chung, J
    View PubMed
  • J UROLOGY 2018 10.1016/j.juro.2018.06.030 Changeable Conditional Survival Rates and Associated Prognosticators in Patients with Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy Kang1, M; Park, JY; Jeong, CW; Hwang, EC; Song, C; Hong, SH; Kwak, C; Chung, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • CLIN GENITOURIN CANC 2018 10.1016/j.clgc.2018.02.015 Role of PI-RADS Version 2 for Prediction of Upgrading in Biopsy-Proven Prostate Cancer With Gleason Score 6 Song1, W; Bang, SH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Kim, CK; Lee, HM
    View PubMed
  • EUR RADIOL 2018 10.1007/s00330-018-5305-6 RFA versus robotic partial nephrectomy for T1a renal cell carcinoma: a propensity score-matched comparison of mid-term outcome Park1, BK; Gong, IH; Kang, MY; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Seo, SI
    View PubMed
  • OncoTargets and therapy 2018 10.2147/OTT.S169094 The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study Song1, W; Yu, JW; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kang, ES; Jeon, HG
    View PubMed
  • INT J UROL 2018 10.1111/iju.13574 Prognostic impact of the pretreatment aspartate transaminase/alanine transaminase ratio in patients treated with first-line systemic tyrosine kinase inhibitor therapy for metastatic renal cell carcinoma Kang1, M; Yu, J; Sung, HH; Jeon, HG; Jeong, BC; Park, SH; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • J Healthc Eng 2018 10.1155/2018/4651582 A Deep Belief Network and Dempster-Shafer-Based Multiclassifier for the Pathology Stage of Prostate Cancer Kim1, JK; Choi, MJ; Lee, JS; Hong, JH; Kim, CS; Seo, SI; Jeong, CW; Byun, SS; Koo, KC; Chung, BH; Park, YH; Lee, JY; Choi, IY
    View PubMed
  • TRANSL ONCOL 2018 10.1016/j.tranon.2017.10.008 Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract Lee1, JY; Kim, K; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Kwon, GY; Kim, KM; Lee, J; Lim, HY; Park, SH
    View PubMed
  • PLoS One 2018 10.1371/journal.pone.0191786 Comparisons of oncological outcomes and perioperative complications between laparoscopic and open radical nephrectomies in patients with clinical T2 renal cell carcinoma (>= 7cm) Lee1, H; Lee, CU; Yoo, JH; Sung, HH; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Jeong, CW; Kwak, C; Il Seo, S
    View PubMed
  • UROLOGY 2018 10.1016/j.urology.2017.06.006 Comparison of the Effect of Naftopidil 75 mg and Tamsulosin 0.2 mg on the Bladder Storage Symptom With Benign Prostatic Hyperplasia: Prospective, Multi-institutional Study Kwon1, SY; Lee, KS; Yoo, TK; Chung, JI; Lee, JY; Hong, JH; Seo, SI; Jung, TY; Kwak, C; Kang, TW; Yun, SJ
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2016.477 Selection Criteria for Active Surveillance of Patients with Prostate Cancer in Korea: A Multicenter Analysis of Pathology after Radical Prostatectomy Jeong1, CW; Hong, SK; Byun, SS; Jeon, SS; Seo, SI; Lee, HM; Ahn, H; Kwon, DD; Ha, HK; Kwon, TG; Chung, JS; Kwak, C; Kim, HJ
    View PubMed
  • J ENDOUROL 2017 10.1089/end.2017.0369 Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients with Localized Renal Cell Carcinoma Kang1, M; Gong, IH; Park, HJ; Sung, HH; Jeon, HG; Jeong, BC; Jeon, SS; Lee, HM; Choi, HY; Seo, SI
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.05.008 Preoperative Cholesterol Level Is Associated With Worse Pathological Outcomes and Postoperative Survival in Localized Renal Cell Carcinoma Patients: A Propensity Score-Matched Study Lee1, H; Jeong, CW; Kwak, C; Kim, HH; Il Seo, S; Lee, HM; Oh, JJ; Lee, SC; Hong, SK; Lee, SE; Byun, SS
    View PubMed
  • ANN SURG ONCOL 2017 10.1245/s10434-017-6065-2 y Prognostic Significance of Pre- to Postoperative Dynamics of the Prognostic Nutritional Index for Patients with Renal Cell Carcinoma Who Underwent Radical Nephrectomy Kang1, M; Chang, CT; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM
    View PubMed
  • PLoS One 2017 10.1371/journal.pone.0186026 Comparative rates of upstaging and upgrading in Caucasian and Korean prostate cancer patients eligible for active surveillance Jeon1, HG; Yoo, JH; Jeong, BC; Seo, SI; Jeon, SS; Choi, HY; Lee, HM; Ferrari, M; Brooks, JD; Chung, BI
    View PubMed
  • J CANCER RES CLIN 2017 10.1007/s00432-017-2502-7 Impact of Gleason score on biochemical recurrence in patients with pT3aN0/Nx prostate cancer with positive surgical margins: a multicenter study from the Prostate Cancer Research Committee Song1, W; Lee, DH; Jeon, HG; Jeong, BC; Seo, SI; Lee, HM; Choi, HY; Kim, JW; Lee, S; Byun, SS; Jeong, CW; Kwak, C; Cho, JS; Ahn, H; Jeon, SS
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.04.015 Clinicopathologic Characteristics and Prognosis of Xp11.2 Translocation Renal Cell Carcinoma: Multicenter, Propensity Score Matching Analysis Choo1, MS; Jeong, CW; Song, C; Jeon, HG; Seo, SI; Hong, SK; Byun, SS; Chung, JS; Hong, SH; Hwang, EC; Kim, HH; Kwak, C
    View PubMed
  • SURG ONCOL 2017 10.1016/j.suronc.2017.04.003 Endoscopic management of upper tract urothelial carcinoma: Improved prediction of invasive cancer using a ureteroscopic scoring model Jeon1, SS; Sung, HH; Jeon, HG; Han, DH; Jeong, BC; Seo, SI; Lee, HM; Choi, HY
    View PubMed
  • CLIN GENITOURIN CANC 2017 10.1016/j.clgc.2017.01.015 Comparison of Oncologic Outcomes and Complications According to Surgical Approach to Radical Prostatectomy: Special Focus on the Perineal Approach Song1, W; Park, JH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY
    View PubMed
  • BMC UROL 2017 10.1186/s12894-017-0253-z A retrospective feasibility study of biweekly, reduced-dose docetaxel in Asian patients with castrate-resistant, metastatic prostate cancer Kim1, HS; Lee, JY; Lee, SJ; Lim, HY; Sung, HH; Jeon, HG; Jeong, BC; Seo, SI; Jeon, SS; Lee, HM; Choi, HY; Park, SH
    View PubMed
  • Asian J Androl. 2017 May-Jun;19(3):346-349. doi: 10.4103/1008-682X.172826. Mutation of MED12 is not a frequent occurrence in, prostate cancer of Korean patients Yoon N11, Lim S1, Kang SY1, Kwon GY1, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • J Urol. 2017 Apr;197(4):991-997. doi: 10.1016/j.juro.2016.10.055. Epub 2016 Oct 17. Postoperative Outcome of Cystic Renal Cell Carcinoma Defined on Preoperative Imaging: A Retrospective Study Park JJ11, Jeong BC2, Kim CK3, Seo SI2, Carriere KC4, Kim M5, Park BK6, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • Urol Oncol. 2017 Mar;35(3):114.e1-114.e7. doi: 10.1016/j.urolonc.2016.10.022. Epub 2016 Nov 28. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Biomed Res Int. 2017;2017:9215930. doi: 10.1155/2017/9215930. Epub 2017 Feb 7. Primary Tumor Characteristics Are Important Prognostic Factors for Sorafenib-Treated Patients with Metastatic Renal Cell Carcinoma: A Retrospective Multicenter Study Kim SH11, Kim S2, Nam BH3, Lee SE4, Kim CS5, Seo IY6, Kim TN7, Hong SH8, Kwon TG9, Seo SI10, Joo KJ11, Song K12, Kwak C13, Chung J1.
    View PubMed
  • INTERNATIONAL JOURNAL OF UROLOGY, FEB 2017, 24(2):102-109, DOI: 10.1111/iju.13272 Surgical treatment of renal cell carcinoma: Can morphological features of inferior vena cava tumor thrombus on computed tomography or magnetic resonance imaging be a prognostic factor? Choi DK1, Jeon HG, Jeong CW, Kwak C, Song C, Chung J, Hong SK, Hong SH, Seo S
    View PubMed
  • Scand J Urol. 2017 Feb;51(1):27-32. doi: 10.1080/21681805.2016.1266384. Development of a new nomogram to predict insignificant prostate cancer in patients undergoing radical prostatectomy Kim TH11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • Int Urol Nephrol. 2017 Feb;49(2):191-196. doi: 10.1007/s11255-016-1458-x. Epub 2016 Nov 25. Clinical significance of incidentally detected bladder wall thickening on computed tomography Song W11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Oncotarget. 2016 Dec 13;7(50):83735-83743. doi: 10.18632/oncotarget.13407. Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer Song W11, Kwon GY2, Kim JH3, Lim JE4, Jeon HG1, Il Seo S1, Jeon SS1, Choi HY1, Jeong BC1, Lee HM1.
    View PubMed
  • J Korean Med Sci. 2016 Dec;31(12):1983-1988. doi: 10.3346/jkms.2016.31.12.1983. A Prospective Multicenter Trial of the Efficacy and Tolerability of Neoadjuvant Sunitinib for Inoperable Metastatic Renal Cell Carcinoma Kim SH11, Seo SI2, Lee HM2, Choi HY2, Jeon SH3, Lee HL3, Kwon TG4, Kim YJ5, Kim WJ5, Chung J6.
    View PubMed
  • Can Urol Assoc J. 2016 Nov-Dec;10(11-12):E377-E382. doi: 10.5489/cuaj.3896. Epub 2016 Nov 10. Relationship between Gleason score and apparent diffusion coefficients of diffusion-weighted magnetic resonance imaging in prostate cancer patients Kim TH11, Kim CK2, Park BK2, Jeon HG3, Jeong BC3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3.
    View PubMed
  • Oncotarget. 2016 Sep 27;7(39):63870-63886. doi: 10.18632/oncotarget.11563. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2 Park BH11, Lim JE2, Jeon HG3, Seo SI3, Lee HM3, Choi HY3, Jeon SS3, Jeong BC3.
    View PubMed
  • Oncotarget. 2016 Aug 9;7(32):51626-51639. doi: 10.18632/oncotarget.10539. Establishment and antitumor effects of dasatinib and PKI-587 in BD-138T, a patient-derived muscle invasive bladder cancer preclinical platform with concomitant EGFR amplification and PTEN deletion Chang N11,2,3, Lee HW3,4, Lim JE5, Jeong DE1, Song HJ6, Kim S3,7, Nam DH1,2,3, Sung HH5, Jeong BC5, Seo SI5, Jeon SS5, Lee HM5, Choi HY5, Jeon HG5.
    View PubMed
  • J Endourol. 2016 Jul;30(7):783-91. doi: 10.1089/end.2015.0652. Epub 2016 May 26. Oncological Outcomes in Patients Treated with Radical Cystectomy for Bladder Cancer: Comparison Between Open, Laparoscopic, and Robot-Assisted Approaches Kim TH11, Sung HH2, Jeon HG2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeong BC2.
    View PubMed
  • J Clin Pathol. 2016 Jul;69(7):586-92. doi: 10.1136/jclinpath-2015-203314. Epub 2015 Dec 15. Correlation of ERG immunohistochemistry with molecular detection of TMPRSS2-ERG gene fusion Sung JY11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Kang SY3, Choi YL3, Kwon GY3.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):472-7. doi: 10.1111/iju.13077. Epub 2016 Mar 14. Comparison of preoperative adaptive enlargement of the contralateral normal kidney in patients nephrectomized for benign non-functioning kidney versus renal cell carcinoma Song W11, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG1.
    View PubMed
  • Int J Urol. 2016 Jun;23(6):465-71. doi: 10.1111/iju.13084. Epub 2016 Mar 28. Renal cell carcinoma in end-stage renal disease: Multi-institutional comparative analysis of survival Song C11, Hong SH2, Chung JS3, Byun SS4, Kwak C5, Jeong CW5, Seo SI6, Jeon HG6, Seo IY7.
    View PubMed
  • Int Urol Nephrol. 2016 Jun;48(6):977-83. doi: 10.1007/s11255-016-1250-y. Epub 2016 Feb 26. Tumor size is associated with compensatory hypertrophy in the contralateral kidney after radical nephrectomy in patients with renal cell carcinoma Park BH11, Sung HH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • Urology. 2016 Apr;90:119-24. doi: 10.1016/j.urology.2015.10.051. Epub 2016 Jan 11. Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma Lee SW11, Sung HH1, Jeon HG1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Seo SI2.
    View PubMed
  • UROLOGY, APR 2016, 90:124-125, DOI: 10.1016/j.urology.2015.10.053 Size and Volumetric Growth Kinetics of Renal Masses in Patients With Renal Cell Carcinoma REPLY Lee SW1, Il Seo S
    View PubMed
  • J Urol. 2016 Mar;195(3):568-73. doi: 10.1016/j.juro.2015.09.073. Epub 2015 Sep 26. Percutaneous Kidney Biopsy for a Small Renal Mass: A Critical Appraisal of Results Jeon HG11, Seo SI1, Jeong BC1, Jeon SS1, Lee HM1, Choi HY1, Song C1, Hong JH1, Kim CS1, Ahn H1, Jeong IG2.
    View PubMed
  • World J Urol. 2016 Jan;34(1):63-8. doi: 10.1007/s00345-015-1551-2. Epub 2015 Apr 3. Volumetric measurement of compensatory hypertrophy in the contralateral normal kidney by the tumor growth Park BH11, Jeong BC2, Jeon SS2, Seo SI2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • World J Urol. 2016 Jan;34(1):83-8. doi: 10.1007/s00345-015-1592-6. Epub 2015 May 17. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma Song W11, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Int J Urol. 2016 Jan;23(1):56-61. doi: 10.1111/iju.12960. Epub 2015 Oct 26. Prognostic factors after salvage radiotherapy alone in patients with biochemical recurrence after radical prostatectomy Song W11, Jeon HG1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • Ann Surg Oncol. 2016 Jan;23(1):321-7. doi: 10.1245/s10434-015-4614-0. Epub 2015 Jun 5. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival in Renal Cell Carcinoma Patients Undergoing Nephrectomy Jeon HG11, Choi DK1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Eur Radiol. 2015 Nov;25(11):3143-50. doi: 10.1007/s00330-015-3741-0. Epub 2015 May 8. Measurement of renal function in a kidney donor: a comparison of creatinine-based and volume-based GFRs Choi DK11, Choi SM1, Park BH2, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG3.
    View PubMed
  • J Korean Med Sci. 2015 Nov;30(11):1631-7. doi: 10.3346/jkms.2015.30.11.1631. Epub 2015 Oct 16. Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2.
    View PubMed
  • PLoS One. 2015 Nov 10;10(11):e0139976. doi: 10.1371/journal.pone.0139976. eCollection 2015. Diagnostic Ureterorenoscopy Is Associated with Increased Intravesical Recurrence following Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma Sung HH11, Jeon HG1, Han DH1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • PLoS One. 2015 Nov 24;10(11):e0141709. doi: 10.1371/journal.pone.0141709. eCollection 2015. Trends in the Use of Nephron-Sparing Surgery over 7 Years: An Analysis Using the RENAL Nephrometry Scoring System Shin SJ11, Ko KJ1, Kim TS1, Ryoo HS1, Sung HH1, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS1.
    View PubMed
  • J Urol. 2015 Oct;194(4):910-5. doi: 10.1016/j.juro.2015.04.093. Epub 2015 Apr 28. Compensatory Structural and Functional Adaptation after Radical Nephrectomy for Renal Cell Carcinoma According to Preoperative Stage of Chronic Kidney Disease Choi DK11, Jung SB1, Park BH1, Jeong BC1, Seo SI1, Jeon SS1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • Can Urol Assoc J. 2015 Sep-Oct;9(9-10):E705-8. doi: 10.5489/cuaj.2855. Epub 2015 Oct 13. Clinicohistological characteristics of renal cell carcinoma in children: A multicentre study Kim JH11, Seo SI2, Song C3, Chung J4, Kwak C5, Hong SH6.
    View PubMed
  • J Korean Med Sci. 2015 Sep;30(9):1321-7. doi: 10.3346/jkms.2015.30.9.1321. Epub 2015 Aug 13. Diagnostic and Prognostic Significance of Radiologic Node-positive Renal Cell Carcinoma in the Absence of Distant Metastases: A Retrospective Analysis of Patients Undergoing Nephrectomy and Lymph Node Dissection Lee HW11, Jeon HG2, Jeong BC2, Seo SI2, Jeon SS2, Choi HY2, Lee HM2.
    View PubMed
  • Eur Radiol. 2015 Jun;25(6):1786-92. doi: 10.1007/s00330-014-3566-2. Epub 2015 Jan 31. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance Kim TH11, Jeong JY, Lee SW, Kim CK, Park BK, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Choi HY, Jeon SS.
    View PubMed
  • Int J Urol. 2015 May;22(5):455-61. doi: 10.1111/iju.12716. Epub 2015 Jan 29. Prognostic significance of visceral obesity in patients with advanced renal cell carcinoma undergoing nephrectomy Lee HW11, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG.
    View PubMed
  • BJU Int. 2015 Apr;115(4):587-94. doi: 10.1111/bju.12846. Epub 2014 Dec 7. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma Sung HH11, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • PLoS One. 2015 Mar 23;10(3):e0122019. doi: 10.1371/journal.pone.0122019. eCollection 2015. A Comparison of Radiologic Tumor Volume and Pathologic Tumor Volume in Renal Cell Carcinoma (RCC) Choi SM11, Choi DK2, Kim TH2, Jeong BC2, Seo SI2, Jeon SS2, Lee HM2, Choi HY2, Jeon HG3.
    View PubMed
  • J Korean Med Sci. 2015 Mar;30(3):317-22. doi: 10.3346/jkms.2015.30.3.317. Epub 2015 Feb 16. Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges Lee HW11, Jeon HG1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM1.
    View PubMed
  • Int J Urol. 2015 Jan;22(1):82-7. doi: 10.1111/iju.12604. Epub 2014 Sep 10. Significance of early prostate-specific antigen values after salvage radiotherapy in recurrent prostate cancer patients treated with surgery Chang JH11, Park W, Park JS, Pyo H, Huh SJ, Choi HY, Lee HM, Jeon SS, Seo SI.
    View PubMed
  • World J Urol. 2014 Dec;32(6):1523-9. doi: 10.1007/s00345-014-1312-7. Epub 2014 May 10. Transperitoneal versus retroperitoneal robotic partial nephrectomy: matched-pair comparisons by nephrometry scores Choo SH11, Lee SY, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Korean Med Sci. 2014 Dec;29(12):1688-93. doi: 10.3346/jkms.2014.29.12.1688. Epub 2014 Nov 21. Interval from Prostate Biopsy to Radical Prostatectomy Does Not Affect Immediate Operative Outcomes for Open or Minimally Invasive Approach Park B11, Choo SH2, Jeon HG3, Jeong BC3, Seo SI3, Jeon SS3, Lee HM3, Choi HY3.
    View PubMed
  • Urology. 2014 Nov;84(5):1001-7. doi: 10.1016/j.urology.2014.06.052. Epub 2014 Oct 24. Incidence and Management of Extended-spectrum Beta-lactamase and Quinolone-resistant Escherichia coli Infections After Prostate Biopsy Song W11, Choo SH1, Sung HH1, Han DH1, Jeong BC1, Seo SI1, Jeon SS1, Lee KS1, Lee SW1, Lee HM1, Choi HY1, Jeon HG2.
    View PubMed
  • J Urol. 2014 Jul;192(1):82-8. doi: 10.1016/j.juro.2014.01.005. Epub 2014 Jan 15. Influence of Magnetic Resonance Imaging in the Decision to Preserve or Resect Neurovascular Bundles at Robotic Assisted Laparoscopic Radical Prostatectomy Park BH11, Jeon HG1, Jeong BC1, Seo SI1, Lee HM1, Choi HY1, Jeon SS2.
    View PubMed
  • BJU Int. 2014 Jun;113(6):864-70. doi: 10.1111/bju.12423. Epub 2013 Dec 2. Role of multiparametric 3.0-Tesla magnetic resonance imaging in patients with prostate cancer eligible for active surveillance Park BH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Int J Urol. 2014 Apr;21(4):377-81. doi: 10.1111/iju.12326. Epub 2013 Oct 29. Pathological upgrading and upstaging of patients eligible for active surveillance according to currently used protocols Kim TH11, Jeon HG, Choo SH, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Urol Oncol. 2014 Jan;32(1):49.e23-31. doi: 10.1016/j.urolonc.2013.07.015. FGFR3 overexpression is prognostic of adverse outcome for muscle-invasive bladder carcinoma treated with adjuvant chemotherapy Sung JY11, Sun JM2, Chang Jeong B3, Il Seo S3, Soo Jeon S3, Moo Lee H3, Yong Choi H3, Young Kang S4, Choi YL5, Young Kwon G6.
    View PubMed
  • J Clin Pathol. 2014 Jan;67(1):49-54. doi: 10.1136/jclinpath-2013-201799. Epub 2013 Aug 12. Clinical significance of micropapillary urothelial carcinoma of the upper urinary tract Sung HH11, Cho J, Kwon GY, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM.
    View PubMed
  • Eur J Cancer. 2014 Jan;50(1):64-9. doi: 10.1016/j.ejca.2013.08.018. Epub 2013 Sep 20. Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinoma Jeon HG11, Choo SH1, Sung HH1, Jeong BC1, Seo SI1, Jeon SS1, Choi HY1, Lee HM2.
    View PubMed
  • Yonsei Med J. 2013 Jul;54(4):912-20. doi: 10.3349/ymj.2013.54.4.912. Pure Laparoscopic Radical Cystectomy with heal Conduit: A Single Surgeon's Mid-Term Outcomes 1,Pure Laparoscopic Radical Cystectomy with heal Conduit: A Single Surgeon's Mid-Term Outcomes
    View PubMed
  • JSLS. 2013 Apr-Jun;17(2):292-9. doi: 10.4293/108680813X13693422521359. A Comparison of Surgical and Functional Outcomes of Robot-Assisted Versus Pure Laparoscopic Partial Nephrectomy Choi JD11, Park JW, Lee HW, Lee DG, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • Int J Cancer. 2013 Feb 1;132(3):625-34. doi: 10.1002/ijc.27639. Epub 2012 Jun 20. Body mass index and survival in patients with renal cell carcinoma: A clinical-based cohort and meta-analysis Choi Y11, Park B, Jeong BC, Seo SI, Jeon SS, Choi HY, Adami HO, Lee JE, Lee HM.
    View PubMed
  • Scand J Urol. 2013 Feb;47(1):10-8. doi: 10.3109/00365599.2012.696137. Epub 2012 Jul 27. Comparison of oncological and functional outcomes of pure versus robotic-assisted laparoscopic radical prostatectomy performed by a single surgeon Park B11, Kim W, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Urol. 2012 Mar;187(3):802-6. doi: 10.1016/j.juro.2011.10.140. Epub 2012 Jan 15. Does Prolonged Warm Ischemia After Partial Nephrectomy Under Pneumoperitoneum Cause Irreversible Damage to the Affected Kidney Choi JD11, Park JW, Lee SY, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Endourol. 2011 Apr;25(4):597-602. doi: 10.1089/end.2010.0229. Epub 2011 Mar 25. Comparative Assessment of a Single Surgeon's Series of Laparoscopic Radical Prostatectomy: Conventional Versus Robot-Assisted Park JW11, Won Lee H, Kim W, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • Eur Urol. 2010 Dec;58(6):900-5. doi: 10.1016/j.eururo.2010.08.044. Epub 2010 Sep 15. Renal Damage Caused by Warm Ischaemia During Laparoscopic and Robot-Assisted Partial Nephrectomy: An Assessment Using Tc 99m-DTPA Glomerular Filtration Rate Choi JD11, Park JW, Choi JY, Kim HS, Jeong BC, Jeon SS, Lee HM, Choi HY, Seo SI.
    View PubMed
  • J Endourol. 2010 Sep;24(9):1435-40. doi: 10.1089/end.2009.0638. Robot-Assisted Radical Cystectomy and Pelvic Lymph Node Dissection: A Multi-Institutional Study from Korea Kang SG11, Kang SH, Lee YG, Rha KH, Jeong BC, Ko YH, Lee HM, Seo SI, Kwon TG, Park SC, Jung SI, Sung GT, Kim HH.
    View PubMed
  • Yonsei Med J. 2010 Sep;51(5):700-7. doi: 10.3349/ymj.2010.51.5.700. Can We Predict Real T3 Stage Prostate Cancer in Patients with Clinical T3 (cT3) Disease before Radical Prostatectomy Lee HW11, Seo SI, Jeon SS, Lee HM, Choi HY.
    View PubMed
  • Tumori. 2010 Jan-Feb;96(1):138-42. Expression analysis of caspase-6, caspase-9 and BNIP3 in prostate cancer Yoo NJ11, Kim MS, Park SW, Seo SI, Song SY, Lee JY, Lee SH.
    View PubMed
  • APMIS. 2009 Aug;117(8):623-8. doi: 10.1111/j.1600-0463.2009.02506.x. Immunohistochemical analysis of NF-kappa B signaling proteins IKK epsilon, p50/p105, p52/p100 and RelA in prostate cancers Seo SI11, Song SY, Kang MR, Kim MS, Oh JE, Kim YR, Lee JY, Yoo NJ, Lee SH.
    View PubMed
  • Int J Cancer. 2009 Jul 15;125(2):353-5. doi: 10.1002/ijc.24379. Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers Kang MR11, Kim MS, Oh JE, Kim YR, Song SY, Seo SI, Lee JY, Yoo NJ, Lee SH.
    View PubMed
  • Clin Cancer Res. 2008 Oct 1;14(19):6198-206. doi: 10.1158/1078-0432.CCR-08-1023. BKM1740, an Acyl-Tyrosine Bisphosphonate Amide Derivative, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells by Inducing Apoptosis Seo SI11, Gera L, Zhau HE, Qian WP, Iqbal S, Johnson NA, Zhang S, Zayzafoon M, Stewart J, Wang R, Chung LW, Wu D.
    View PubMed